# Efficacy and Clinical Outcomes of Levosimendan in E-CPR

> **NCT05730907** · — · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 100 (estimated)

## Conditions studied

- Cardiogenic Shock
- Extracorporeal Membrane Oxygenation Complication

## Interventions

- **DRUG:** Levosimendan

## Key facts

- **NCT ID:** NCT05730907
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-20
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05730907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05730907, "Efficacy and Clinical Outcomes of Levosimendan in E-CPR". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05730907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*